Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

Published:2013-01-24 Issue:4 Volume:15 Page:372-382
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Stenlöf K.¹,Cefalu W. T.²³,Kim K.‐A.⁴,Alba M.⁵,Usiskin K.⁵,Tong C.⁵,Canovatchel W.⁵,Meininger G.⁵

Affiliation:

1. Clinical Trial Center Sahlgrenska University Hospital Gothenburg Sweden

2. Pennington Biomedical Research Center Baton Rouge LA USA

3. LSUHSC School of Medicine New Orleans LA USA

4. Department of Internal Medicine Dongguk University Ilsan Hospital, Dongguk University School of Medicine Goyang South Korea

5. Janssen Research & Development LLC Raritan NJ USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12054

Reference22 articles.

1. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

2. Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes

3. Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care

4. The importance of β-cell management in type 2 diabetes

5. Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations

Cited by 518 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of canagliflozin and teneligliptin on energy intake and body weight in Japanese patients with Type 2 diabetes: a subanalysis of the CANTABILE study;BMC Endocrine Disorders;2024-08-19

2. Impact of canagliflozin combined with metformin therapy on reducing cardiovascular risk in type 2 diabetes patients;Diabetology & Metabolic Syndrome;2024-08-17

3. Sodium-Glucose Cotransporter 2 Inhibitors and Mycotic Genital or Urinary Tract Infections in Heart Failure;Journal of Cardiac Failure;2024-08

4. Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial;Diabetes, Obesity and Metabolism;2024-07-26

5. Bexagliflozin: a comprehensive review of a recently approved SGLT2 inhibitor for the treatment of type 2 diabetes mellitus;Medicinal Chemistry Research;2024-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3